|Poll|May 13, 2014

Pruritic, Burning Perioral “Lesions”: Your Dx?

Listen

0:00 / 0:00

Key Takeaways

Angular cheilitis presents as pruritic, red, burning patches at the mouth corners, often linked to nutritional deficiencies or infections.
Diagnosis involves clinical examination and may require lab tests to identify underlying causes.
Treatment depends on etiology, including topical antifungals, antibiotics, or addressing nutritional deficiencies.
Proper management is essential to alleviate symptoms and prevent recurrence by addressing the root cause.

Do you recognize these symptomatic red patches and plaques? What underlying disorder does the condition imply?

[[{"type":"media","view_mode":"media_crop","fid":"24473","attributes":{"alt":"","class":"media-image","id":"media_crop_290608919623","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2116","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]

This woman was concerned about pruritic, red, burning patches at both corners of her mouth.

What are these lesions--and what are the clinical implications of the diagnosis?

Join thousands of clinicians staying current on new therapies, trial data, and expert insights—subscribe to HCPLive today.

Related to this article

September 21st, 2026

Q&A: Zasocitinib Response in the Scalp, Nails, Palms and Soles

Raj Chovatiya, MD, PhD, on zasocitinib results in the scalp, nails, palms and soles, speed of response and once-daily oral dosing in psoriasis.

September 21st, 2026

PAH Experts Discuss Trial-to-Clinic Mismatch in Care

Philadelphia-area PAH specialists discuss real-world patient mismatch with trial criteria, drug sequencing, and insurance access barriers.

September 21st, 2026

FAQ: What the Expanded Marstacimab Approval Means for Hemophilia A, B

FDA expands marstacimab approval to children and patients with inhibitors, backed by new BASIS trial data.

September 21st, 2026

Binge Drinking and ALD, MetALD Fibrosis Risk, With Frances Lee, MD

Frances Lee, MD, on stigma's role in ALD care and why women may progress to advanced disease faster than men.

September 21st, 2026

Q&A: Zasocitinib's Role Beyond Topicals in Moderate to Severe Psoriasis

In this Q&A, Raj Chovatiya, MD, PhD, discusses where zasocitinib fits in the psoriasis treatment algorithm and what high clearance rates mean for patients.